Why the study?
Rotaviruses remain a leading cause of diarrhea mortality in children under 5 years, and improving oral rotavirus vaccines has been delayed by an incomplete understanding of rotavirus immunity.
Does depletion of LAP+ cells improve protection induced by oral rhesus rotavirus vaccination in neonatal mice?
Does depletion of LAP+ cells improve protection induced by oral rhesus rotavirus vaccination in neonatal mice?
Depletion of LAP+ regulatory T cells improves the protective efficacy of oral live rotavirus vaccines in a neonatal mouse model.
LAP+ Tregs may shape intestinal rotavirus immunity; leaves open their role in next-generation vaccines.
Despite the introduction of several live attenuated animal and human rotaviruses as efficient oral vaccines, rotaviruses continue to be the leading etiological agent for diarrhea mortality among children under 5 years of age worldwide. Improvement of these vaccines has been partially delayed because immunity to rotaviruses is incompletely understood. In the intestine (where rotavirus replicates), regulatory T cells that express latency-associated peptide (LAP) play a prominent role, which has been explored for many diseases but not specifically for infectious agents. In this paper, we show that neonatal mice given a live oral rotavirus vaccine develop rotavirus-specific LAP + T cells and that depletion of these cells improves the efficiency of the vaccine. These findings may prove useful for the design of strategies to improve rotavirus vaccines.
No takes yet. Share an insight, caveat, or question.
Rey et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: